Skip to main content
SpringerLink
Log in

Immunoproteomics: Current Technology and Applications

  • Protocol
  • First Online:
Book cover Immunoproteomics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1061))

Abstract

The varied landscape of the adaptive immune response is determined by the peptides presented by immune cells, derived from viral or microbial pathogens or cancerous cells. The study of immune biomarkers or antigens is not new and classical methods such as agglutination, enzyme-linked immunosorbent assay, or Western blotting have been used for many years to study the immune response to vaccination or disease. However, in many of these traditional techniques, protein or peptide identification has often been the bottleneck. Recent advances in genomics and proteomics, has led to many of the rapid advances in proteomics approaches. Immunoproteomics describes a rapidly growing collection of approaches that have the common goal of identifying and measuring antigenic peptides or proteins. This includes gel based, array based, mass spectrometry, DNA based, or in silico approaches. Immunoproteomics is yielding an understanding of disease and disease progression, vaccine candidates, and biomarkers. This review gives an overview of immunoproteomics and closely related technologies that are used to define the full set of antigens targeted by the immune system during disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jungblut PR (2001) Proteome analysis of bacterial pathogens. Microbes Infect 3:831–840

    Article  PubMed  CAS  Google Scholar 

  2. McComb D, Thiriot A, Krishnan L, Stark F (2013) Introduction to the immune system. Immunoproteomics. Methods Mol Biol 1061:1–20

    Google Scholar 

  3. O'Farrell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007–4021

    PubMed  Google Scholar 

  4. Haas G, Karaali G, Ebermayer K, Metzger WG, Lamer S, Zimny-Arndt U, Diescher S, Goebel UB, Vogt K, Roznowski AB, Wiedenmann BJ, Meyer TF, Aebischer T, Jungblut PR (2002) Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2:313–324

    Article  PubMed  CAS  Google Scholar 

  5. Chen Z, Peng B, Wang S, Peng X (2004) Rapid screening of highly efficient vaccine candidates by immunoproteomics. Proteomics 4:3203–3213

    Article  PubMed  CAS  Google Scholar 

  6. Krah A, Miehlke S, Pleissner KP, Zimny-Arndt U, Kirsch C, Lehn N, Meyer TF, Jungblut PR, Aebischer T (2004) Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer 108:456–463

    Article  PubMed  CAS  Google Scholar 

  7. Peng X, Ye X, Wang S (2004) Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies. Vaccine 22:2750–2756

    Article  PubMed  CAS  Google Scholar 

  8. Ying T, Wang H, Li M, Wang J, Shi Z, Feng E, Liu X, Su G, Wei K, Zhang X, Huang P, Huang L (2005) Immunoproteomics of outer membrane proteins and extracellular proteins of Shigella flexneri 2a 2457T. Proteomics 5:4777–4793

    Article  PubMed  CAS  Google Scholar 

  9. Ying TY, Wang JJ, Wang HL, Feng EL, Wei KH, Huang LY, Huang PT, Huang CF (2005) Immunoproteomics of membrane proteins of Shigella flexneri 2a 2457T. World J Gastroenterol 11:6880–6883

    PubMed  CAS  Google Scholar 

  10. Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, Chafin R, Grewal P, Mujer CV, Ugalde RA, DelVecchio VG (2006) Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics 6:3767–3780

    Article  PubMed  CAS  Google Scholar 

  11. Falisse-Poirrier N, Ruelle V, ElMoualij B, Zorzi D, Pierard O, Heinen E, De Pauw E, Zorzi W (2006) Advances in immunoproteomics for serological characterization of microbial antigens. J Microbiol Methods 67:593–596

    Article  PubMed  CAS  Google Scholar 

  12. Mini R, Bernardini G, Salzano AM, Renzone G, Scaloni A, Figura N, Santucci A (2006) Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J Chromatogr B Analyt Technol Biomed Life Sci 833:63–79

    Article  PubMed  CAS  Google Scholar 

  13. Paul-Satyaseela M, Karched M, Bian Z, Ihalin R, Boren T, Arnqvist A, Chen C, Asikainen S (2006) Immunoproteomics of Actinobacillus actinomycetemcomitans outer-membrane proteins reveal a highly immunoreactive peptidoglycan-associated lipoprotein. J Med Microbiol 55:931–942

    Article  PubMed  CAS  Google Scholar 

  14. Bernardini G, Braconi D, Lusini P, Santucci A (2007) Helicobacter pylori, immunoproteomics related to different pathologies. Expert Rev Proteomics 4:679–689

    Article  PubMed  CAS  Google Scholar 

  15. Hagan EC, Mobley HL (2007) Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 75:3941–3949

    Article  PubMed  CAS  Google Scholar 

  16. Janovska S, Pavkova I, Reichelova M, Hubaleka M, Stulik J, Macela A (2007) Proteomic analysis of antibody response in a case of laboratory-acquired infection with Francisella tularensis subsp. tularensis. Folia Microbiol (Praha) 52:194–198

    Article  CAS  Google Scholar 

  17. Shin GW, Palaksha KJ, Kim YR, Nho SW, Kim S, Heo GJ, Park SC, Jung TS (2007) Application of immunoproteomics in developing a Streptococcus iniae vaccine for olive flounder (Paralichthys olivaceus). J Chromatogr B Analyt Technol Biomed Life Sci 849:315–322

    Article  PubMed  CAS  Google Scholar 

  18. Zhang W, Lu CP (2007) Immunoproteomics of extracellular proteins of Chinese virulent strains of Streptococcus suis type 2. Proteomics 7:4468–4476

    Article  PubMed  CAS  Google Scholar 

  19. Li H, Xiong XP, Peng B, Xu CX, Ye MZ, Yang TC, Wang SY, Peng XX (2009) Identification of broad cross-protective immunogens using heterogeneous antiserum-based immunoproteomic approach. J Proteome Res 8:4342–4349

    Article  PubMed  CAS  Google Scholar 

  20. Park SH, Kwon SJ, Lee SJ, Kim YC, Hwang KY, Kang YH, Lee KJ (2009) Identification of immunogenic antigen candidate for Chlamydophila pneumoniae diagnosis. J Proteome Res 8:2933–2943

    Article  PubMed  CAS  Google Scholar 

  21. Lahner E, Bernardini G, Santucci A, Annibale B (2010) Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics 7:239–248

    Article  PubMed  CAS  Google Scholar 

  22. Li H, Ye MZ, Peng B, Wu HK, Xu CX, Xiong XP, Wang C, Wang SY, Peng XX (2010) Immunoproteomic identification of polyvalent vaccine candidates from Vibrio parahaemolyticus outer membrane proteins. J Proteome Res 9:2573–2583

    Article  PubMed  CAS  Google Scholar 

  23. Roy K, Bartels S, Qadri F, Fleckenstein JM (2010) Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins. Infect Immun 78:3027–3035

    Article  PubMed  CAS  Google Scholar 

  24. Santi L, Silva WO, Pinto AF, Schrank A, Vainstein MH (2010) Metarhizium anisopliae host-pathogen interaction, differential immunoproteomics reveals proteins involved in the infection process of arthropods. Fungal Biol 114:312–319

    Article  PubMed  CAS  Google Scholar 

  25. Lahner E, Bernardini G, Possenti S, Renzone G, Scaloni A, Santucci A, Annibale B (2011) Immunoproteomics of Helicobacter pylori infection in patients with atrophic body gastritis, a predisposing condition for gastric cancer. Int J Med Microbiol 301:125–132

    Article  PubMed  CAS  Google Scholar 

  26. Wang Y, Dang Y, Wang X, Lu H, Lang X, Li X, Feng S, Zhang F, Ren L (2011) Comparative proteomic analyses of Streptococcus suis serotype 2 cell wall-associated proteins. Curr Microbiol 62:578–588

    Article  PubMed  CAS  Google Scholar 

  27. Yang Y, Wang L, Yin J, Wang X, Cheng S, Lang X, Qu H, Sun C, Wang J, Zhang R (2011) Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine. Mol Immunol 49:175–184

    Article  PubMed  CAS  Google Scholar 

  28. Hu Q, Ding C, Tu J, Wang X, Han X, Duan Y, Yu S (2012) Immunoproteomics analysis of whole cell bacterial proteins of Riemerella anatipestifer. Vet Microbiol 157:428–438

    Article  PubMed  CAS  Google Scholar 

  29. Pajuaba AC, Silva DA, Almeida KC, Cunha-Junior JP, Pirovani CP, Camillo LR, Mineo JR (2012) Immunoproteomics of Brucella abortus reveals differential antibody profiles between S19-vaccinated and naturally infected cattle. Proteomics 12:820–831

    Article  PubMed  CAS  Google Scholar 

  30. Cha HJ, Yoon HG, Kim YW, Lee HS, Kim JW, Kweon KS, Oh BH, Park KH (1998) Molecular and enzymatic characterization of a maltogenic amylase that hydrolyzes and transglycosylates acarbose. Eur J Biochem 253:251–262

    Article  PubMed  CAS  Google Scholar 

  31. Hamrita B, Chahed K, Kabbage M, Guillier CL, Trimeche M, Chaieb A, Chouchane L (2008) Identification of tumor antigens that elicit a humoral immune response in breast cancer patients’ sera by serological proteome analysis (SERPA). Clin Chim Acta 393:95–102

    Article  PubMed  CAS  Google Scholar 

  32. Li L, Chen SH, Yu CH, Li YM, Wang SQ (2008) Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray. J Proteome Res 7:611–620

    Article  PubMed  CAS  Google Scholar 

  33. Forgber M, Gellrich S, Sharav T, Sterry W, Walden P (2009) Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphoma. PLoS One 4:e8376

    Article  PubMed  CAS  Google Scholar 

  34. Forgber M, Trefzer U, Sterry W, Walden P (2009) Proteome serological determination of tumor-associated antigens in melanoma. PLoS One 4:e5199

    Article  PubMed  CAS  Google Scholar 

  35. Mou Z, He Y, Wu Y (2009) Immunoproteomics to identify tumor-associated antigens eliciting humoral response. Cancer Lett 278:123–129

    Article  PubMed  CAS  Google Scholar 

  36. Shukla S, Pranay A, D'Cruz AK, Chaturvedi P, Kane SV, Zingde SM (2009) Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response. Cancer Biomark 5:127–135

    PubMed  CAS  Google Scholar 

  37. Liu R, Wang K, Yuan K, Wei Y, Huang C (2010) Integrative oncoproteomics strategies for anticancer drug discovery. Expert Rev Proteomics 7:411–429

    Article  PubMed  CAS  Google Scholar 

  38. Suzuki A, Iizuka A, Komiyama M, Takikawa M, Kume A, Tai S, Ohshita C, Kurusu A, Nakamura Y, Yamamoto A, Yamazaki N, Yoshikawa S, Kiyohara Y, Akiyama Y (2010) Identification of melanoma antigens using a Serological Proteome Approach (SERPA). Cancer Genomics Proteomics 7:17–23

    PubMed  CAS  Google Scholar 

  39. Mojtahedi Z, Safaei A, Yousefi Z, Ghaderi A (2011) Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes. OMICS 15:409–418

    Article  PubMed  CAS  Google Scholar 

  40. O'Meara MM, Disis ML (2011) Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic, emerging applications toward proof of concept. OMICS 15:579–588

    Article  PubMed  CAS  Google Scholar 

  41. Almeras L, Lefranc D, Drobecq H, de Seze J, Dubucquoi S, Vermersch P, Prin L (2004) New antigenic candidates in multiple sclerosis, identification by serological proteome analysis. Proteomics 4:2184–2194

    Article  PubMed  CAS  Google Scholar 

  42. Xiong X, Wang X, Wen B, Graves S, Stenos J (2012) Potential serodiagnostic markers for Q fever identified in Coxiella burnetii by immunoproteomic and protein microarray approaches. BMC Microbiol 12:35

    Article  PubMed  CAS  Google Scholar 

  43. Kornilovs'ka I, Nilsson I, Utt M, Ljungh A, Wadstrom T (2002) Immunogenic proteins of Helicobacter pullorum, Helicobacter bilis and Helicobacter hepaticus identified by two-dimensional gel electrophoresis and immunoblotting. Proteomics 2:775–783

    Article  PubMed  Google Scholar 

  44. Utt M, Nilsson I, Ljungh A, Wadstrom T (2002) Identification of novel immunogenic proteins of Helicobacter pylori by proteome technology. J Immunol Methods 259:1–10

    Article  PubMed  CAS  Google Scholar 

  45. Zhong ZR, Zhou HB, Li XY, Luo QL, Song XR, Wang W, Wen HQ, Yu L, Wei W, Shen JL (2010) Serological proteome-oriented screening and application of antigens for the diagnosis of Schistosomiasis japonica. Acta Trop 116:1–8

    Article  PubMed  CAS  Google Scholar 

  46. Chitlaru T, Gat O, Grosfeld H, Inbar I, Gozlan Y, Shafferman A (2007) Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome. Infect Immun 75:2841–2852

    Article  PubMed  CAS  Google Scholar 

  47. Zhu YZ, Cai CS, Zhang W, Guo HX, Zhang JP, Ji YY, Ma GY, Wu JL, Li QT, Lu CP, Guo XK (2010) Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV). PLoS One 5:e13915

    Article  PubMed  CAS  Google Scholar 

  48. Fulton KM, Zhao X, Petit MD, Kilmury SL, Wolfraim LA, House RV, Sjostedt A, Twine SM (2011) Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination. Int J Med Microbiol 301:591–601

    Article  PubMed  CAS  Google Scholar 

  49. Davies DH, Liang X, Hernandez JE, Randall A, Hirst S, Mu Y, Romero KM, Nguyen TT, Kalantari-Dehaghi M, Crotty S, Baldi P, Villarreal LP, Felgner PL (2005) Profiling the humoral immune response to infection by using proteome microarrays, high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A 102:547–552

    Article  PubMed  CAS  Google Scholar 

  50. Eyles JE, Unal B, Hartley MG, Newstead SL, Flick-Smith H, Prior JL, Oyston PC, Randall A, Mu Y, Hirst S, Molina DM, Davies DH, Milne T, Griffin KF, Baldi P, Titball RW, Felgner PL (2007) Immunodominant Francisella tularensis antigens identified using proteome microarray. Proteomics 7:2172–2183

    Article  PubMed  CAS  Google Scholar 

  51. Sundaresh S, Doolan DL, Hirst S, Mu Y, Unal B, Davies DH, Felgner PL, Baldi P (2006) Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 22:1760–1766

    Article  PubMed  CAS  Google Scholar 

  52. Fang Y, Frutos AG, Lahiri J (2002) Membrane protein microarrays. J Am Chem Soc 124:2394–2395

    Article  PubMed  CAS  Google Scholar 

  53. Shin I, Cho JW, Boo DW (2004) Carbohydrate arrays for functional studies of carbohydrates. Comb Chem High Throughput Screen 7:565–574

    Article  PubMed  CAS  Google Scholar 

  54. Davies DH, Molina DM, Wrammert J, Miller J, Hirst S, Mu Y, Pablo J, Unal B, Nakajima-Sasaki R, Liang X, Crotty S, Karem KL, Damon IK, Ahmed R, Villarreal L, Felgner PL (2007) Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 7:1678–1686

    Article  PubMed  CAS  Google Scholar 

  55. Benhnia MR, Maybeno M, Blum D, Aguilar-Sino R, Matho M, Meng X, Head S, Felgner PL, Zajonc DM, Koriazova L, Kato S, Burton DR, Xiang Y, Crowe JE Jr, Peters B, Crotty S (2013) Unusual features of vaccinia virus extracellular virion form (EV) neutralization resistance revealed in human antibody responses to the smallpox vaccine. J Virol 87:1569–1585

    Google Scholar 

  56. Cruz-Fisher MI, Cheng C, Sun G, Pal S, Teng A, Molina DM, Kayala MA, Vigil A, Baldi P, Felgner PL, Liang X, de la Maza LM (2011) Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice. Infect Immun 79:246–257

    Article  PubMed  CAS  Google Scholar 

  57. Teng A, Cruz-Fisher MI, Cheng C, Pal S, Sun G, Ralli-Jain P, Molina DM, Felgner PL, Liang X, de la Maza LM (2012) Proteomic identification of immunodominant chlamydial antigens in a mouse model. J Proteomics 77:176–186

    Article  PubMed  CAS  Google Scholar 

  58. Conejero L, Patel N, de Reynal M, Oberdorf S, Prior J, Felgner PL, Titball RW, Salguero FJ, Bancroft GJ (2011) Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosis. Am J Pathol 179:270–280

    Article  PubMed  Google Scholar 

  59. Cannella AP, Tsolis RM, Liang L, Felgner PL, Saito M, Sette A, Gotuzzo E, Vinetz JM (2012) Antigen-specific acquired immunity in human brucellosis, implications for diagnosis, prognosis, and vaccine development. Front Cell Infect Microbiol 2:1

    Article  PubMed  CAS  Google Scholar 

  60. Kunnath-Velayudhan S, Salamon H, Wang HY, Davidow AL, Molina DM, Huynh VT, Cirillo DM, Michel G, Talbot EA, Perkins MD, Felgner PL, Liang X, Gennaro ML (2010) Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc Natl Acad Sci U S A 107:14703–14708

    Article  PubMed  CAS  Google Scholar 

  61. Kunnath-Velayudhan S, Davidow AL, Wang HY, Molina DM, Huynh VT, Salamon H, Pine R, Michel G, Perkins MD, Xiaowu L, Felgner PL, Flynn JL, Catanzaro A, Gennaro ML (2012) Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients. J Infect Dis 206:697–705

    Article  PubMed  Google Scholar 

  62. Lee SJ, Liang L, Juarez S, Nanton MR, Gondwe EN, Msefula CL, Kayala MA, Necchi F, Heath JN, Hart P, Tsolis RM, Heyderman RS, MacLennan CA, Felgner PL, Davies DH, McSorley SJ (2012) Identification of a common immune signature in murine and human systemic Salmonellosis. Proc Natl Acad Sci U S A 109:4998–5003

    Article  PubMed  CAS  Google Scholar 

  63. Dasgupta G, Chentoufi AA, Kalantari M, Falatoonzadeh P, Chun S, Lim CH, Felgner PL, Davies DH, BenMohamed L (2012) Immunodominant “asymptomatic” herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individuals. J Virol 86:4358–4369

    Article  PubMed  CAS  Google Scholar 

  64. Kalantari-Dehaghi M, Chun S, Chentoufi AA, Pablo J, Liang L, Dasgupta G, Molina DM, Jasinskas A, Nakajima-Sasaki R, Felgner J, Hermanson G, BenMohamed L, Felgner PL, Davies DH (2012) Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling. J Virol 86:4328–4339

    Article  PubMed  CAS  Google Scholar 

  65. Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, Valdez C, Randall A, Molina D, Liang X, Freilich DA, Oloo JA, Blair PL, Aguiar JC, Baldi P, Davies DH, Felgner PL (2008) Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8:4680–4694

    Article  PubMed  CAS  Google Scholar 

  66. Barry AE, Trieu A, Fowkes FJ, Pablo J, Kalantari-Dehaghi M, Jasinskas A, Tan X, Kayala MA, Tavul L, Siba PM, Day KP, Baldi P, Felgner PL, Doolan DL (2011) The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area. Mol Cell Proteomics 10:M111 008326

    PubMed  Google Scholar 

  67. Nnedu ON, O'Leary MP, Mutua D, Mutai B, Kalantari-Dehaghi M, Jasinskas A, Nakajima-Sasaki R, John-Stewart G, Otieno P, Liang X, Waitumbi J, Kimani F, Camerini D, Felgner PL, Walson JL, Vigil A (2011) Humoral immune responses to Plasmodium falciparum among HIV-1-infected Kenyan adults. Proteomics Clin Appl 5:613–623

    Article  PubMed  CAS  Google Scholar 

  68. Fan YT, Wang Y, Ju C, Zhang T, Xu B, Hu W, Chen JH (2013) Systematic analysis of natural antibody responses to P. falciparum merozoite antigens by protein arrays. J Proteomics 78:148–158

    Google Scholar 

  69. Beare PA, Chen C, Bouman T, Pablo J, Unal B, Cockrell DC, Brown WC, Barbian KD, Porcella SF, Samuel JE, Felgner PL, Heinzen RA (2008) Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray. Clin Vaccine Immunol 15:1771–1779

    Article  PubMed  CAS  Google Scholar 

  70. Vigil A, Chen C, Jain A, Nakajima-Sasaki R, Jasinskas A, Pablo J, Hendrix LR, Samuel JE, Felgner PL (2011) Profiling the humoral immune response of acute and chronic Q fever by protein microarray. Mol Cell Proteomics 10:M110 006304

    PubMed  Google Scholar 

  71. Liang L, Doskaya M, Juarez S, Caner A, Jasinskas A, Tan X, Hajagos BE, Bradley PJ, Korkmaz M, Guruz Y, Felgner PL, Davies DH (2011) Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey. Mol Cell Proteomics 10:M110 006916

    PubMed  Google Scholar 

  72. Suwannasaen D, Mahawantung J, Chaowagul W, Limmathurotsakul D, Felgner PL, Davies H, Bancroft GJ, Titball RW, Lertmemongkolchai G (2011) Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis. J Infect Dis 203:1002–1011

    Article  PubMed  CAS  Google Scholar 

  73. Barbour AG, Jasinskas A, Kayala MA, Davies DH, Steere AC, Baldi P, Felgner PL (2008) A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect Immun 76:3374–3389

    Article  PubMed  CAS  Google Scholar 

  74. Sundaresh S, Randall A, Unal B, Petersen JM, Belisle JT, Hartley MG, Duffield M, Titball RW, Davies DH, Felgner PL, Baldi P (2007) From protein microarrays to diagnostic antigen discovery, a study of the pathogen Francisella tularensis. Bioinformatics 23:i508–i518

    Article  PubMed  CAS  Google Scholar 

  75. Zheng D, Wan J, Cho YG, Wang L, Chiou CJ, Pai S, Woodard C, Zhu J, Liao G, Martinez-Maza O, Qian J, Zhu H, Hayward GS, Ambinder RF, Hayward SD (2011) Comparison of humoral immune responses to Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus using a viral proteome microarray. J Infect Dis 204:1683–1691

    Article  PubMed  CAS  Google Scholar 

  76. Hakomori S (2002) Glycosylation defining cancer malignancy, new wine in an old bottle. Proc Natl Acad Sci U S A 99:10231–10233

    Article  PubMed  CAS  Google Scholar 

  77. Coenen D, Verschueren P, Westhovens R, Bossuyt X (2007) Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem 53:498–504

    Article  PubMed  CAS  Google Scholar 

  78. Hiki Y (2009) O-linked oligosaccharides of the IgA1 hinge region, roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy. Clin Exp Nephrol 13:415–423

    Article  PubMed  CAS  Google Scholar 

  79. Schietinger A, Philip M, Yoshida BA, Azadi P, Liu H, Meredith SC, Schreiber H (2006) A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science 314:304–308

    Article  PubMed  CAS  Google Scholar 

  80. Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, Mandel U, Ragupathi G, Livingston PO, Hollingsworth MA, Taylor-Papadimitriou J, Burchell J, Clausen H (2010) Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res 70:1306–1313

    Article  PubMed  CAS  Google Scholar 

  81. Smorodin EP, Kurtenkov OA, Shevchuk IN, Tanner RH (2005) The isolation and characterization of human natural alphaGal-specific IgG antibodies applicable to the detection of alphaGal-glycosphingolipids. J Immunoassay Immunochem 26:145–156

    Article  PubMed  CAS  Google Scholar 

  82. Reis CA, David L, Seixas M, Burchell J, Sobrinho-Simoes M (1998) Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int J Cancer 79:402–410

    Article  PubMed  CAS  Google Scholar 

  83. Brockhausen I (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1473:67–95

    Article  PubMed  CAS  Google Scholar 

  84. Blixt O, Clo E, Nudelman AS, Sorensen KK, Clausen T, Wandall HH, Livingston PO, Clausen H, Jensen KJ (2010) A high-throughput O-glycopeptide discovery platform for seromic profiling. J Proteome Res 9:5250–5261

    Article  PubMed  CAS  Google Scholar 

  85. Kracun SK, Clo E, Clausen H, Levery SB, Jensen KJ, Blixt O (2010) Random glycopeptide bead libraries for seromic biomarker discovery. J Proteome Res 9:6705–6714

    Article  PubMed  CAS  Google Scholar 

  86. Pedersen JW, Blixt O, Bennett EP, Tarp MA, Dar I, Mandel U, Poulsen SS, Pedersen AE, Rasmussen S, Jess P, Clausen H, Wandall HH (2011) Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int J Cancer 128:1860–1871

    Article  PubMed  CAS  Google Scholar 

  87. Reis CA, Campos D, Osorio H, Santos LL (2011) Glycopeptide microarray for autoantibody detection in cancer. Expert Rev Proteomics 8:435–437

    Article  PubMed  CAS  Google Scholar 

  88. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689–10692

    Article  PubMed  CAS  Google Scholar 

  89. Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B (2000) Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci U S A 97:2163–2167

    Article  PubMed  CAS  Google Scholar 

  90. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, Coyle AJ, DiStefano PS, Bertin J, Sansonetti PJ, Philpott DJ (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584–1587

    Article  PubMed  CAS  Google Scholar 

  91. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869–8872

    Article  PubMed  CAS  Google Scholar 

  92. Girardin SE, Hugot JP, Sansonetti PJ (2003) Lessons from Nod2 studies, towards a link between Crohn’s disease and bacterial sensing. Trends Immunol 24:652–658

    Article  PubMed  CAS  Google Scholar 

  93. Girardin SE, Travassos LH, Herve M, Blanot D, Boneca IG, Philpott DJ, Sansonetti PJ, Mengin-Lecreulx D (2003) Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 278:41702–41708

    Article  PubMed  CAS  Google Scholar 

  94. Verma A, Arora SK, Kuravi SK, Ramphal R (2005) Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect Immun 73:8237–8246

    Article  PubMed  CAS  Google Scholar 

  95. Doig P, Kinsella N, Guerry P, Trust TJ (1996) Characterization of a post-translational modification of Campylobacter flagellin, identification of a sero-specific glycosyl moiety. Mol Microbiol 19:379–387

    Article  PubMed  CAS  Google Scholar 

  96. Horn C, Namane A, Pescher P, Riviere M, Romain F, Puzo G, Barzu O, Marchal G (1999) Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern. J Biol Chem 274:32023–32030

    Article  PubMed  CAS  Google Scholar 

  97. Romain F, Horn C, Pescher P, Namane A, Riviere M, Puzo G, Barzu O, Marchal G (1999) Deglycosylation of the 45/47-kilodalton antigen complex of Mycobacterium tuberculosis decreases its capacity to elicit in vivo or in vitro cellular immune responses. Infect Immun 67:5567–5572

    PubMed  CAS  Google Scholar 

  98. Logan SM, Kelly JF, Thibault P, Ewing CP, Guerry P (2002) Structural heterogeneity of carbohydrate modifications affects serospecificity of Campylobacter flagellins. Mol Microbiol 46:587–597

    Article  PubMed  CAS  Google Scholar 

  99. Mehta AS, Saile E, Zhong W, Buskas T, Carlson R, Kannenberg E, Reed Y, Quinn CP, Boons GJ (2006) Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium. Chemistry 12:9136–9149

    Article  PubMed  CAS  Google Scholar 

  100. Wang D, Carroll GT, Turro NJ, Koberstein JT, Kovac P, Saksena R, Adamo R, Herzenberg LA, Steinman L (2007) Photogenerated glycan arrays identify immunogenic sugar moieties of Bacillus anthracis exosporium. Proteomics 7:180–184

    Article  PubMed  CAS  Google Scholar 

  101. Dhenin SG, Moreau V, Morel N, Nevers MC, Volland H, Creminon C, Djedaini-Pilard F (2008) Synthesis of an anthrose derivative and production of polyclonal antibodies for the detection of anthrax spores. Carbohydr Res 343:2101–2110

    Article  PubMed  CAS  Google Scholar 

  102. Dhenin SG, Moreau V, Nevers MC, Creminon C, Djedaini-Pilard F (2009) Sensitive and specific enzyme immunoassays for antigenic trisaccharide from Bacillus anthracis spores. Org Biomol Chem 7:5184–5199

    Article  PubMed  CAS  Google Scholar 

  103. Lee SY, Jeoung D (2007) The reverse proteomics for identification of tumor antigens. J Microbiol Biotechnol 17:879–890

    PubMed  CAS  Google Scholar 

  104. Sahin U, Tureci O, Pfreundschuh M (1997) Serological identification of human tumor antigens. Curr Opin Immunol 9:709–716

    Article  PubMed  CAS  Google Scholar 

  105. Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT, Old LJ (1999) Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 83:456–464

    Article  PubMed  CAS  Google Scholar 

  106. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jager D, Chen YT, Mackay A, O'Hare MJ, Old LJ (2001) Humoral immunity to human breast cancer, antigen definition and quantitative analysis of mRNA expression. Cancer Immun 1:4

    PubMed  CAS  Google Scholar 

  107. Koroleva EP, Lagarkova MA, Mesheryakov AA, Scanlan MJ, Old LJ, Nedospasov SA, Kuprash DV (2002) Serological identification of antigens associated with renal cell carcinoma. Russ J Immunol 7:229–238

    PubMed  Google Scholar 

  108. Devitt G, Meyer C, Wiedemann N, Eichmuller S, Kopp-Schneider A, Haferkamp A, Hautmann R, Zoller M (2006) Serological analysis of human renal cell carcinoma. Int J Cancer 118:2210–2219

    Article  PubMed  CAS  Google Scholar 

  109. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76:652–658

    Article  PubMed  CAS  Google Scholar 

  110. Line A, Slucka Z, Stengrevics A, Silina K, Li G, Rees RC (2002) Characterisation of tumour-associated antigens in colon cancer. Cancer Immunol Immunother 51:574–582

    Article  PubMed  CAS  Google Scholar 

  111. Ishikawa T, Fujita T, Suzuki Y, Okabe S, Yuasa Y, Iwai T, Kawakami Y (2003) Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability. Cancer Res 63:5564–5572

    PubMed  CAS  Google Scholar 

  112. Obata Y, Akahashi T, Tamaki H, Tominaga S, Murai H, Iwase T, Iwata H, Mizutani M, Chen YT, Old LJ, Miura S (1999) Identification of cancer antigens in breast cancer by the SEREX expression cloning method. Breast Cancer 6:305–311

    Article  PubMed  Google Scholar 

  113. Forti S, Scanlan MJ, Invernizzi A, Castiglioni F, Pupa S, Agresti R, Fontanelli R, Morelli D, Old LJ, Pupa SM, Menard S (2002) Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient’s serum. Breast Cancer Res Treat 73:245–256

    Article  PubMed  Google Scholar 

  114. Jager D, Unkelbach M, Frei C, Bert F, Scanlan MJ, Jager E, Old LJ, Chen YT, Knuth A (2002) Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun 2:5

    PubMed  Google Scholar 

  115. Minenkova O, Pucci A, Pavoni E, De Tomassi A, Fortugno P, Gargano N, Cianfriglia M, Barca S, De Placido S, Martignetti A, Felici F, Cortese R, Monaci P (2003) Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int J Cancer 106:534–544

    Article  PubMed  CAS  Google Scholar 

  116. Jager D, Taverna C, Zippelius A, Knuth A (2004) Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer Immunol Immunother 53:144–147

    Article  PubMed  CAS  Google Scholar 

  117. Qian F, Odunsi K, Blatt LM, Scanlan MJ, Mannan M, Shah N, Montgomery J, Haddad F, Taylor M (2005) Tumor associated antigen recognition by autologous serum in patients with breast cancer. Int J Mol Med 15:137–144

    PubMed  CAS  Google Scholar 

  118. Shimada H, Nakashima K, Ochiai T, Nabeya Y, Takiguchi M, Nomura F, Hiwasa T (2005) Serological identification of tumor antigens of esophageal squamous cell carcinoma. Int J Oncol 26:77–86

    PubMed  CAS  Google Scholar 

  119. Jager D (2007) Potential target antigens for immunotherapy identified by serological expression cloning (SEREX). Methods Mol Biol 360:319–326

    PubMed  Google Scholar 

  120. Kiyamova R, Kostianets O, Malyuchik S, Filonenko V, Usenko V, Gurtovyy V, Khozayenko Y, Antonuk S, Old L, Gout I (2010) Identification of tumor-associated antigens from medullary breast carcinoma by a modified SEREX approach. Mol Biotechnol 46:105–112

    Article  PubMed  CAS  Google Scholar 

  121. Song MH, Ha JC, Lee SM, Park YM, Lee SY (2011) Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX. Biochem Biophys Res Commun 408:195–201

    Article  PubMed  CAS  Google Scholar 

  122. Kostianets O, Shyian M, Sergiy D, Antoniuk S, Gout I, Filonenko V, Kiyamova R (2012) Serological analysis of SEREX-defined medullary breast carcinoma-associated antigens. Cancer Invest 30:519–527

    Article  PubMed  CAS  Google Scholar 

  123. Song MH, Choi KU, Shin DH, Lee CH, Lee SY (2012) Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma. Oncol Rep 28:1792–1798

    PubMed  CAS  Google Scholar 

  124. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A 94:1914–1918

    Article  PubMed  CAS  Google Scholar 

  125. Jager E, Jager D, Knuth A (1999) CTL-defined cancer vaccines, perspectives for active immunotherapeutic interventions in minimal residual disease. Cancer Metastasis Rev 18:143–150

    Article  PubMed  CAS  Google Scholar 

  126. Old LJ (2008) Cancer vaccines, an overview. Cancer Immun 8(Suppl 1):1

    PubMed  Google Scholar 

  127. Boder ET, Wittrup KD (1997) Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 15:553–557

    Article  PubMed  CAS  Google Scholar 

  128. Mischo A, Wadle A, Watzig K, Jager D, Stockert E, Santiago D, Ritter G, Regitz E, Jager E, Knuth A, Old L, Pfreundschuh M, Renner C (2003) Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients. Cancer Immun 3:5

    PubMed  Google Scholar 

  129. Wadle A, Mischo A, Imig J, Wullner B, Hensel D, Watzig K, Neumann F, Kubuschok B, Schmidt W, Old LJ, Pfreundschuh M, Renner C (2005) Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library. Int J Cancer 117:104–113

    Article  PubMed  CAS  Google Scholar 

  130. Kim MS, Choi HY, Choi YS, Kim J, Kim YS (2007) Optimized serological isolation of lung-cancer-associated antigens from a yeast surface-expressed cDNA library. J Microbiol Biotechnol 17:993–1001

    PubMed  CAS  Google Scholar 

  131. Jongeneel V (2001) Towards a cancer immunome database. Cancer Immun 1:3

    PubMed  CAS  Google Scholar 

  132. Caron M, Choquet-Kastylevsky G, Joubert-Caron R (2007) Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Proteomics 6:1115–1122

    Article  PubMed  CAS  Google Scholar 

  133. Hardouin J, Lasserre JP, Canelle L, Duchateau M, Vlieghe C, Choquet-Kastylevsky G, Joubert-Caron R, Caron M (2007) Usefulness of autoantigens depletion to detect autoantibody signatures by multiple affinity protein profiling. J Sep Sci 30:352–358

    Article  PubMed  CAS  Google Scholar 

  134. Hardouin J, Lasserre JP, Sylvius L, Joubert-Caron R, Caron M (2007) Cancer immunomics, from serological proteome analysis to multiple affinity protein profiling. Ann N Y Acad Sci 1107:223–230

    Article  PubMed  CAS  Google Scholar 

  135. Roozendaal R, Carroll MC (2007) Complement receptors CD21 and CD35 in humoral immunity. Immunol Rev 219:157–166

    Article  PubMed  CAS  Google Scholar 

  136. Solomon S, Kassahn D, Illges H (2005) The role of the complement and the Fc gamma R system in the pathogenesis of arthritis. Arthritis Res Ther 7:129–135

    Article  PubMed  CAS  Google Scholar 

  137. Croce MV, Fejes M, Riera N, Minoldo DA, Segal-Eiras A (1985) Clinical importance of circulating immune complexes in human acute lymphoblastic leukemia. Cancer Immunol Immunother 20:91–95

    Article  PubMed  CAS  Google Scholar 

  138. Liu P, Overman RG, Yates NL, Alam SM, Vandergrift N, Chen Y, Graw F, Freel SA, Kappes JC, Ochsenbauer C, Montefiori DC, Gao F, Perelson AS, Cohen MS, Haynes BF, Tomaras GD (2011) Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. J Virol 85:11196–11207

    Article  PubMed  CAS  Google Scholar 

  139. Coppo R, Bosticardo GM, Basolo B, Messina M, Mazzucco G, Stratta P, Quarello F, Alloatti S, Piccoli G (1982) Clinical significance of the detection of circulating immune complexes in lupus nephritis. Nephron 32:320–328

    Article  PubMed  CAS  Google Scholar 

  140. Soltis RD, Hasz DE (1983) The effect of serum immunoglobulin concentration on immune complex detection by polyethylene glycol. J Immunol Methods 57:275–282

    Article  PubMed  CAS  Google Scholar 

  141. Valentijn RM, van Overhagen H, Hazevoet HM, Hermans J, Cats A, Daha MR, van EL (1985) The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 28:904–913

    Article  PubMed  CAS  Google Scholar 

  142. Lock RJ, Unsworth DJ (2000) Measurement of immune complexes is not useful in routine clinical practice. Ann Clin Biochem 37(Pt 3):253–261

    Article  PubMed  CAS  Google Scholar 

  143. Ohyama K, Ueki Y, Kawakami A, Kishikawa N, Tamai M, Osaki M, Kamihira S, Nakashima K, Kuroda N (2011) Immune complexome analysis of serum and its application in screening for immune complex antigens in rheumatoid arthritis. Clin Chem 57:905–909

    Article  PubMed  CAS  Google Scholar 

  144. Ohyama K, Kuroda N (2012) Proteomic approaches to profiling the humoral immune response and identifying disease-associated antigens. Biol Pharm Bull 35:1409–1412

    PubMed  CAS  Google Scholar 

  145. Ohyama K, Kawakami A, Tamai M, Baba M, Kishikawa N, Kuroda N (2012) Serum immune complex containing thrombospondin-1, a novel biomarker for early rheumatoid arthritis. Ann Rheum Dis 71:1916–1917

    Article  PubMed  Google Scholar 

  146. Beyer NH, Schou C, Houen G, Heegaard NH (2008) Extraction and identification of electroimmunoprecipitated proteins from agarose gels. J Immunol Methods 330:24–33

    Article  PubMed  CAS  Google Scholar 

  147. Grubb AO (1974) Crossed immunoelectrophoresis and electroimmunoassay of IgG. J Immunol 113:343–347

    PubMed  CAS  Google Scholar 

  148. Grubb AO (1974) Crossed immunoelectrophoresis and electroimmunoassay of IgM. J Immunol 112:1420–1425

    PubMed  CAS  Google Scholar 

  149. Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45–52

    Article  PubMed  CAS  Google Scholar 

  150. Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski Freund N, Weiss Y (2007) Epitope mapping, the first step in developing epitope-based vaccines. BioDrugs 21:145–156

    Article  PubMed  CAS  Google Scholar 

  151. Carter JM, Loomis-Price L (2004) B cell epitope mapping using synthetic peptides. Curr Protoc Immunol Chapter 9, Unit 9 4

    Google Scholar 

  152. Ladner RC (2007) Mapping the epitopes of antibodies. Biotechnol Genet Eng Rev 24:1–30

    Article  PubMed  CAS  Google Scholar 

  153. Hugues S, Malherbe L, Filippi C, Glaichenhaus N (2002) Generation and use of alternative multimers of peptide/MHC complexes. J Immunol Methods 268:83–92

    Article  PubMed  CAS  Google Scholar 

  154. Watts C, Moss CX, Mazzeo D, West MA, Matthews SP, Li DN, Manoury B (2003) Creation versus destruction of T cell epitopes in the class II MHC pathway. Ann N Y Acad Sci 987:9–14

    Article  PubMed  CAS  Google Scholar 

  155. Saunders PM, van Endert P (2011) Running the gauntlet, from peptide generation to antigen presentation by MHC class I. Tissue Antigens 78:161–170

    Article  PubMed  CAS  Google Scholar 

  156. Pogue RR, Eron J, Frelinger JA, Matsui M (1995) Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc Natl Acad Sci U S A 92:8166–8170

    Article  PubMed  CAS  Google Scholar 

  157. Abdel-Motal UM, Friedline R, Poligone B, Pogue-Caley RR, Frelinger JA, Tisch R (2001) Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice. Clin Immunol 101:51–58

    Article  PubMed  CAS  Google Scholar 

  158. Kessler JH, Melief CJ (2007) Identification of T-cell epitopes for cancer immunotherapy. Leukemia 21:1859–1874

    Article  PubMed  CAS  Google Scholar 

  159. Hunt DF, Michel H, Dickinson TA, Shabanowitz J, Cox AL, Sakaguchi K, Appella E, Grey HM, Sette A (1992) Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256:1817–1820

    Article  PubMed  CAS  Google Scholar 

  160. Anthony DD, Lehmann PV (2003) T-cell epitope mapping using the ELISPOT approach. Methods 29:260–269

    Article  PubMed  CAS  Google Scholar 

  161. Koelle DM (2003) Expression cloning for the discovery of viral antigens and epitopes recognized by T cells. Methods 29:213–226

    Article  PubMed  CAS  Google Scholar 

  162. Lemmel C, Stevanovic S (2003) The use of HPLC-MS in T-cell epitope identification. Methods 29:248–259

    Article  PubMed  CAS  Google Scholar 

  163. Wang RF (2003) Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells. Methods 29:227–235

    Article  PubMed  CAS  Google Scholar 

  164. Buus S, Claesson MH (2004) Identifying multiple tumor-specific epitopes from large-scale screening for overexpressed mRNA. Curr Opin Immunol 16:137–142

    Article  PubMed  CAS  Google Scholar 

  165. Wang M, Bai F, Pries M, Buus S, Prause JU, Nissen MH (2006) Identification of MHC class I H-2 Kb/Db-restricted immunogenic peptides derived from retinal proteins. Invest Ophthalmol Vis Sci 47:3939–3945

    Article  PubMed  Google Scholar 

  166. Gunawardana CG, Diamandis EP (2007) High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Lett 249:110–119

    Article  PubMed  CAS  Google Scholar 

  167. Thorn M, Wang M, Kloverpris H, Schmidt EG, Fomsgaard A, Wenandy L, Berntsen A, Brunak S, Buus S, Claesson MH (2007) Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope. Cancer Immunol Immunother 56:1755–1763

    Article  PubMed  CAS  Google Scholar 

  168. Richards KA, Topham D, Chaves FA, Sant AJ (2010) Cutting edge, CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J Immunol 185:4998–5002

    Article  PubMed  CAS  Google Scholar 

  169. Provenzano M, Panelli MC, Mocellin S, Bracci L, Sais G, Stroncek DF, Spagnoli GC, Marincola FM (2006) MHC-peptide specificity and T-cell epitope mapping, where immunotherapy starts. Trends Mol Med 12:465–472

    Article  PubMed  CAS  Google Scholar 

  170. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622–627

    Article  PubMed  CAS  Google Scholar 

  171. Rudensky A, Preston-Hurlburt P, al-Ramadi BK, Rothbard J, Janeway CA Jr (1992) Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359:429–431

    Article  PubMed  CAS  Google Scholar 

  172. Engelhard VH (1994) Structure of peptides associated with MHC class I molecules. Curr Opin Immunol 6:13–23

    Article  PubMed  CAS  Google Scholar 

  173. Engelhard VH (1994) Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol 12:181–207

    Article  PubMed  CAS  Google Scholar 

  174. Alfonso C, Karlsson L (2000) Nonclassical MHC class II molecules. Annu Rev Immunol 18:113–142

    Article  PubMed  CAS  Google Scholar 

  175. Santambrogio L, Strominger JL (2006) The ins and outs of MHC class II proteins in dendritic cells. Immunity 25:857–859

    Article  PubMed  CAS  Google Scholar 

  176. Storkus WJ, Zeh HJ 3rd, Salter RD, Lotze MT (1993) Identification of T-cell epitopes, rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother Emphasis Tumor Immunol 14:94–103

    Article  PubMed  CAS  Google Scholar 

  177. Van Bleek GM, Nathenson SG (1990) Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature 348:213–216

    Article  PubMed  Google Scholar 

  178. Prilliman K, Lindsey M, Zuo Y, Jackson KW, Zhang Y, Hildebrand W (1997) Large-scale production of class I bound peptides, assigning a signature to HLA-B*1501. Immunogenetics 45:379–385

    Article  PubMed  CAS  Google Scholar 

  179. Duyar H, Dengjel J, de Graaf KL, Wiesmuller KH, Stevanovic S, Weissert R (2005) Peptide motif for the rat MHC class II molecule RT1.Da, similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule. Immunogenetics 57:69–76

    Article  PubMed  CAS  Google Scholar 

  180. Fissolo N, Haag S, de Graaf KL, Drews O, Stevanovic S, Rammensee HG, Weissert R (2009) Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients. Mol Cell Proteomics 8:2090–2101

    Article  PubMed  CAS  Google Scholar 

  181. Wahlstrom J, Dengjel J, Persson B, Duyar H, Rammensee HG, Stevanovic S, Eklund A, Weissert R, Grunewald J (2007) Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 117:3576–3582

    Article  PubMed  CAS  Google Scholar 

  182. Demine R, Sherev T, Walden P (2003) Biochemical determination of natural tumor-associated T-cell epitopes. Mol Biotechnol 25:71–78

    Article  PubMed  CAS  Google Scholar 

  183. Verma B, Hawkins OE, Neethling FA, Caseltine SL, Largo SR, Hildebrand WH, Weidanz JA (2010) Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties. Cancer Immunol Immunother 59:563–573

    Article  PubMed  CAS  Google Scholar 

  184. McMurtrey CP, Lelic A, Piazza P, Chakrabarti AK, Yablonsky EJ, Wahl A, Bardet W, Eckerd A, Cook RL, Hess R, Buchli R, Loeb M, Rinaldo CR, Bramson J, Hildebrand WH (2008) Epitope discovery in West Nile virus infection, Identification and immune recognition of viral epitopes. Proc Natl Acad Sci U S A 105:2981–2986

    Article  PubMed  CAS  Google Scholar 

  185. Falk K, Rotzschke O (1993) Consensus motifs and peptide ligands of MHC class I molecules. Semin Immunol 5:81–94

    Article  PubMed  CAS  Google Scholar 

  186. Lemmel C, Weik S, Eberle U, Dengjel J, Kratt T, Becker HD, Rammensee HG, Stevanovic S (2004) Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling. Nat Biotechnol 22:450–454

    Article  PubMed  CAS  Google Scholar 

  187. Bozzacco L, Yu H, Zebroski HA, Dengjel J, Deng H, Mojsov S, Steinman RM (2011) Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res 10:5016–5030

    Article  PubMed  CAS  Google Scholar 

  188. Mester G, Hoffmann V, Stevanovic S (2011) Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell Mol Life Sci 68:1521–1532

    Article  PubMed  CAS  Google Scholar 

  189. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261–1263

    Article  PubMed  CAS  Google Scholar 

  190. Henderson RA, Cox AL, Sakaguchi K, Appella E, Shabanowitz J, Hunt DF, Engelhard VH (1993) Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. Proc Natl Acad Sci U S A 90:10275–10279

    Article  PubMed  CAS  Google Scholar 

  191. Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL Jr (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264:716–719

    Article  PubMed  CAS  Google Scholar 

  192. den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH et al (1995) Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476–1480

    Article  Google Scholar 

  193. Carralot JP, Lemmel C, Stevanovic S, Pascolo S (2008) Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1. Int Immunol 20:1451–1456

    Article  PubMed  CAS  Google Scholar 

  194. Hawkins OE, Vangundy RS, Eckerd AM, Bardet W, Buchli R, Weidanz JA, Hildebrand WH (2008) Identification of breast cancer peptide epitopes presented by HLA-A*0201. J Proteome Res 7:1445–1457

    Article  PubMed  CAS  Google Scholar 

  195. Weinzierl AO, Maurer D, Altenberend F, Schneiderhan-Marra N, Klingel K, Schoor O, Wernet D, Joos T, Rammensee HG, Stevanovic S (2008) A cryptic vascular endothelial growth factor T-cell epitope, identification and characterization by mass spectrometry and T-cell assays. Cancer Res 68:2447–2454

    Article  PubMed  CAS  Google Scholar 

  196. Seward RJ, Drouin EE, Steere AC, Costello CE (2011) Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis. Mol Cell Proteomics 10(M110):002477

    PubMed  Google Scholar 

  197. Park S, Lim Y, Lee D, Cho B, Bang YJ, Sung S, Kim HY, Kim DK, Lee YS, Song Y, Jeoung DI (2003) Identification and characterization of a novel cancer/testis antigen gene CAGE-1. Biochim Biophys Acta 1625:173–182

    Article  PubMed  CAS  Google Scholar 

  198. Gygi SP, Rist B, Griffin TJ, Eng J, Aebersold R (2002) Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags. J Proteome Res 1:47–54

    Article  PubMed  CAS  Google Scholar 

  199. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3:1154–1169

    Article  PubMed  CAS  Google Scholar 

  200. Cagney G, Emili A (2002) De novo peptide sequencing and quantitative profiling of complex protein mixtures using mass-coded abundance tagging. Nat Biotechnol 20:163–170

    Article  PubMed  CAS  Google Scholar 

  201. Tan CT, Croft NP, Dudek NL, Williamson NA, Purcell AW (2011) Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 11:2336–2340

    Article  PubMed  CAS  Google Scholar 

  202. Lange V, Picotti P, Domon B, Aebersold R (2008) Selected reaction monitoring for quantitative proteomics, a tutorial. Mol Syst Biol 4:222

    Article  PubMed  Google Scholar 

  203. Picotti P, Rinner O, Stallmach R, Dautel F, Farrah T, Domon B, Wenschuh H, Aebersold R (2010) High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 7:43–46

    Article  PubMed  CAS  Google Scholar 

  204. Hogan KT, Sutton JN, Chu KU, Busby JA, Shabanowitz J, Hunt DF, Slingluff CL Jr (2005) Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members. Cancer Immunol Immunother 54:359–371

    Article  PubMed  CAS  Google Scholar 

  205. Ishioka GY, Lamont AG, Thomson D, Bulbow N, Gaeta FC, Sette A, Grey HM (1992) MHC interaction and T cell recognition of carbohydrates and glycopeptides. J Immunol 148:2446–2451

    PubMed  CAS  Google Scholar 

  206. Carbone FR, Gleeson PA (1997) Carbohydrates and antigen recognition by T cells. Glycobiology 7:725–730

    Article  PubMed  CAS  Google Scholar 

  207. Kastrup IB, Andersen MH, Elliott T, Haurum JS (2001) MHC-restricted T cell responses against posttranslationally modified peptide antigens. Adv Immunol 78:267–289

    Article  PubMed  CAS  Google Scholar 

  208. Kastrup IB, Stevanovic S, Arsequell G, Valencia G, Zeuthen J, Rammensee HG, Elliott T, Haurum JS (2000) Lectin purified human class I MHC-derived peptides, evidence for presentation of glycopeptides in vivo. Tissue Antigens 56:129–135

    Article  PubMed  CAS  Google Scholar 

  209. Haurum JS, Arsequell G, Lellouch AC, Wong SY, Dwek RA, McMichael AJ, Elliott T (1994) Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes. J Exp Med 180:739–744

    Article  PubMed  CAS  Google Scholar 

  210. Haurum JS, Tan L, Arsequell G, Frodsham P, Lellouch AC, Moss PA, Dwek RA, McMichael AJ, Elliott T (1995) Peptide anchor residue glycosylation, effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition. Eur J Immunol 25:3270–3276

    Article  PubMed  CAS  Google Scholar 

  211. Haurum JS, Hoier IB, Arsequell G, Neisig A, Valencia G, Zeuthen J, Neefjes J, Elliott T (1999) Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J Exp Med 190:145–150

    Article  PubMed  CAS  Google Scholar 

  212. Glithero A, Tormo J, Haurum JS, Arsequell G, Valencia G, Edwards J, Springer S, Townsend A, Pao YL, Wormald M, Dwek RA, Jones EY, Elliott T (1999) Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. Immunity 10:63–74

    Article  PubMed  CAS  Google Scholar 

  213. Zhang H, Li XJ, Martin DB, Aebersold R (2003) Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol 21:660–666

    Article  PubMed  CAS  Google Scholar 

  214. Andersen MH, Bonfill JE, Neisig A, Arsequell G, Sondergaard I, Valencia G, Neefjes J, Zeuthen J, Elliott T, Haurum JS (1999) Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL. J Immunol 163:3812–3818

    PubMed  CAS  Google Scholar 

  215. Zarling AL, Ficarro SB, White FM, Shabanowitz J, Hunt DF, Engelhard VH (2000) Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J Exp Med 192:1755–1762

    Article  PubMed  CAS  Google Scholar 

  216. Meyer VS, Drews O, Gunder M, Hennenlotter J, Rammensee HG, Stevanovic S (2009) Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands. J Proteome Res 8:3666–3674

    Article  PubMed  CAS  Google Scholar 

  217. Zarling AL, Polefrone JM, Evans AM, Mikesh LM, Shabanowitz J, Lewis ST, Engelhard VH, Hunt DF (2006) Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. Proc Natl Acad Sci U S A 103:14889–14894

    Article  PubMed  CAS  Google Scholar 

  218. Depontieu FR, Qian J, Zarling AL, McMiller TL, Salay TM, Norris A, English AM, Shabanowitz J, Engelhard VH, Hunt DF, Topalian SL (2009) Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proc Natl Acad Sci U S A 106:12073–12078

    Article  PubMed  CAS  Google Scholar 

  219. Li Y, Depontieu FR, Sidney J, Salay TM, Engelhard VH, Hunt DF, Sette A, Topalian SL, Mariuzza RA (2010) Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells. J Mol Biol 399:596–603

    Article  PubMed  CAS  Google Scholar 

  220. Dinarello CA (2007) Historical insights into cytokines. Eur J Immunol 37(Suppl 1):S34–S45

    Article  PubMed  CAS  Google Scholar 

  221. Dinarello CA (2010) Anti-inflammatory agents, present and future. Cell 140:935–950

    Article  PubMed  CAS  Google Scholar 

  222. Bruserud O, Kittang AO (2010) The chemokine system in experimental and clinical hematology. Curr Top Microbiol Immunol 341:3–12

    Article  PubMed  CAS  Google Scholar 

  223. Pult I, Netter HJ, Bruns M, Prassolov A, Sirma H, Hohenberg H, Chang SF, Frolich K, Krone O, Kaleta EF, Will H (2001) Identification and analysis of a new hepadnavirus in white storks. Virology 289:114–128

    Article  PubMed  CAS  Google Scholar 

  224. Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA (2008) ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 63:879–884

    Article  PubMed  Google Scholar 

  225. Yu X, Schneiderhan-Marra N, Hsu HY, Bachmann J, Joos TO (2009) Protein microarrays, effective tools for the study of inflammatory diseases. Methods Mol Biol 577:199–214

    Article  PubMed  CAS  Google Scholar 

  226. Han KC, Ahn DR, Yang EG (2010) An approach to multiplexing an immunosorbent assay with antibody-oligonucleotide conjugates. Bioconjug Chem 21:2190–2196

    Article  PubMed  CAS  Google Scholar 

  227. Szarka A, Rigo J Jr, Lazar L, Beko G, Molvarec A (2010) Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 11:59

    Article  PubMed  CAS  Google Scholar 

  228. Yu X, Hartmann M, Wang Q, Poetz O, Schneiderhan-Marra N, Stoll D, Kazmaier C, Joos TO (2010) microFBI, a microfluidic bead-based immunoassay for multiplexed detection of proteins from a microL sample volume. PLoS One 1:e3125

    Google Scholar 

  229. Han KC, Yang EG, Ahn DR (2012) A highly sensitive, multiplex immunoassay using gold nanoparticle-enhanced signal amplification. Chem Commun (Camb) 48:5895–5897

    Article  CAS  Google Scholar 

  230. Fuson KL, Zheng M, Craxton M, Pataer A, Ramesh R, Chada S, Sutton RB (2009) Structural mapping of post-translational modifications in human interleukin-24, role of N-linked glycosylation and disulfide bonds in secretion and activity. J Biol Chem 284:30526–30533

    Article  PubMed  CAS  Google Scholar 

  231. Guzman NA, Phillips TM (2005) Immunoaffinity CE for proteomics studies. Anal Chem 77:61A–67A

    Article  PubMed  Google Scholar 

  232. Guzman NA, Blanc T, Phillips TM (2008) Immunoaffinity capillary electrophoresis as a powerful strategy for the quantification of low-abundance biomarkers, drugs, and metabolites in biological matrices. Electrophoresis 29:3259–3278

    Article  PubMed  CAS  Google Scholar 

  233. Guzman NA, Phillips TM (2011) Immunoaffinity capillary electrophoresis, a new versatile tool for determining protein biomarkers in inflammatory processes. Electrophoresis 32:1565–1578

    PubMed  CAS  Google Scholar 

  234. Boyle MD, Hess JL, Nuara AA, Buller RM (2006) Application of immunoproteomics to rapid cytokine detection. Methods 38:342–350

    Article  PubMed  CAS  Google Scholar 

  235. Hortin GL, Sviridov D, Anderson NL (2008) High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin Chem 54:1608–1616

    Article  PubMed  CAS  Google Scholar 

  236. Bjorhall K, Miliotis T, Davidsson P (2005) Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5:307–317

    Article  PubMed  CAS  Google Scholar 

  237. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD (2003) Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2:1096–1103

    Article  PubMed  CAS  Google Scholar 

  238. Harper RG, Workman SR, Schuetzner S, Timperman AT, Sutton JN (2004) Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry. Electrophoresis 25:1299–1306

    Article  PubMed  CAS  Google Scholar 

  239. Groessl M, Luksch H, Rosen-Wolff A, Shevchenko A, Gentzel M (2012) Profiling of the human monocytic cell secretome by quantitative label-free mass spectrometry identifies stimulus-specific cytokines and proinflammatory proteins. Proteomics 12:2833–2842

    Article  PubMed  CAS  Google Scholar 

  240. Van Regenmortel MH (2009) What is a B-cell epitope? Methods Mol Biol 524:3–20

    Article  PubMed  CAS  Google Scholar 

  241. Greenbaum JA, Andersen PH, Blythe M, Bui HH, Cachau RE, Crowe J, Davies M, Kolaskar AS, Lund O, Morrison S, Mumey B, Ofran Y, Pellequer JL, Pinilla C, Ponomarenko JV, Raghava GP, van Regenmortel MH, Roggen EL, Sette A, Schlessinger A, Sollner J, Zand M, Peters B (2007) Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J Mol Recognit 20:75–82

    Article  PubMed  CAS  Google Scholar 

  242. Saha S, Bhasin M, Raghava GP (2005) Bcipep, a database of B-cell epitopes. BMC Genomics 6:79

    Article  PubMed  CAS  Google Scholar 

  243. Haste Andersen P, Nielsen M, Lund O (2006) Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 15:2558–2567

    Article  PubMed  CAS  Google Scholar 

  244. Moreau V, Granier C, Villard S, Laune D, Molina F (2006) Discontinuous epitope prediction based on mimotope analysis. Bioinformatics 22:1088–1095

    Article  PubMed  CAS  Google Scholar 

  245. Saha S, Raghava GP (2006) Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65:40–48

    Article  PubMed  CAS  Google Scholar 

  246. Bublil EM, Freund NT, Mayrose I, Penn O, Roitburd-Berman A, Rubinstein ND, Pupko T, Gershoni JM (2007) Stepwise prediction of conformational discontinuous B-cell epitopes using the Mapitope algorithm. Proteins 68:294–304

    Article  PubMed  CAS  Google Scholar 

  247. Saha S, Raghava GP (2007) Prediction methods for B-cell epitopes. Methods Mol Biol 409:387–394

    Article  PubMed  CAS  Google Scholar 

  248. Saha S, Raghava GP (2007) Searching and mapping of B-cell epitopes in Bcipep database. Methods Mol Biol 409:113–124

    Article  PubMed  CAS  Google Scholar 

  249. Moreau V, Fleury C, Piquer D, Nguyen C, Novali N, Villard S, Laune D, Granier C, Molina F (2008) PEPOP, computational design of immunogenic peptides. BMC Bioinformatics 9:71

    Article  PubMed  CAS  Google Scholar 

  250. Ponomarenko J, Bui HH, Li W, Fusseder N, Bourne PE, Sette A, Peters B (2008) ElliPro, a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 9:514

    Article  PubMed  CAS  Google Scholar 

  251. Sweredoski MJ, Baldi P (2008) PEPITO, improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure. Bioinformatics 24:1459–1460

    Article  PubMed  CAS  Google Scholar 

  252. Sun J, Wu D, Xu T, Wang X, Xu X, Tao L, Li YX, Cao ZW (2009) SEPPA, a computational server for spatial epitope prediction of protein antigens. Nucleic Acids Res 37:W612–W616

    Article  PubMed  CAS  Google Scholar 

  253. Liang S, Zheng D, Standley DM, Yao B, Zacharias M, Zhang C (2010) EPSVR and EPMeta, prediction of antigenic epitopes using support vector regression and multiple server results. BMC Bioinformatics 11:381

    Article  PubMed  CAS  Google Scholar 

  254. Zhang W, Xiong Y, Zhao M, Zou H, Ye X, Liu J (2011) Prediction of conformational B-cell epitopes from 3D structures by random forests with a distance-based feature. BMC Bioinformatics 12:341

    Article  PubMed  CAS  Google Scholar 

  255. Evans MC (2008) Recent advances in immunoinformatics, application of in silico tools to drug development. Curr Opin Drug Discov Devel 11:233–241

    PubMed  CAS  Google Scholar 

  256. Bublil EM, Yeger-Azuz S, Gershoni JM (2006) Computational prediction of the cross-reactive neutralizing epitope corresponding to the [corrected] monclonal [corrected] antibody b12 specific for HIV-1 gp120. FASEB J 20:1762–1774

    Article  PubMed  CAS  Google Scholar 

  257. Tong JC, Ren EC (2009) Immunoinformatics, current trends and future directions. Drug Discov Today 14:684–689

    Article  PubMed  CAS  Google Scholar 

  258. Tomar N, De RK (2010) Immunoinformatics, an integrated scenario. Immunology 131:153–168

    Article  PubMed  CAS  Google Scholar 

  259. Bordner AJ, Mittelmann HD (2010) MultiRTA, a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes. BMC Bioinformatics 11:482

    Article  PubMed  CAS  Google Scholar 

  260. Bordner AJ, Abagyan R (2006) Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes. Proteins 63:512–526

    Article  PubMed  CAS  Google Scholar 

  261. Tsurui H, Takahashi T (2007) Prediction of T-cell epitope. J Pharmacol Sci 105:299–316

    Article  PubMed  CAS  Google Scholar 

  262. Lundegaard C, Lund O, Buus S, Nielsen M (2010) Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 130:309–318

    Article  PubMed  CAS  Google Scholar 

  263. Lundegaard C, Lund O, Nielsen M (2011) Prediction of epitopes using neural network based methods. J Immunol Methods 374:26–34

    Article  PubMed  CAS  Google Scholar 

  264. Doolan DL, Aguiar JC, Weiss WR, Sette A, Felgner PL, Regis DP, Quinones-Casas P, Yates JR 3rd, Blair PL, Richie TL, Hoffman SL, Carucci DJ (2003) Utilization of genomic sequence information to develop malaria vaccines. J Exp Biol 206:3789–3802

    Article  PubMed  CAS  Google Scholar 

  265. Moise L, McMurry JA, Buus S, Frey S, Martin WD, De Groot AS (2009) In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes. Vaccine 27:6471–6479

    Article  PubMed  CAS  Google Scholar 

  266. Walshe VA, Hattotuwagama CK, Doytchinova IA, Wong M, Macdonald IK, Mulder A, Claas FH, Pellegrino P, Turner J, Williams I, Turnbull EL, Borrow P, Flower DR (2009) Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102, a bioinformatic approach to the prediction of new epitopes. PLoS One 4:e8095

    Article  PubMed  CAS  Google Scholar 

  267. Driguez P, Doolan DL, Loukas A, Felgner PL, McManus DP (2010) Schistosomiasis vaccine discovery using immunomics. Parasit Vectors 3:4

    Article  PubMed  CAS  Google Scholar 

  268. Schirle M, Keilholz W, Weber B, Gouttefangeas C, Dumrese T, Becker HD, Stevanovic S, Rammensee HG (2000) Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach. Eur J Immunol 30:2216–2225

    Article  PubMed  CAS  Google Scholar 

  269. Pascolo S, Schirle M, Guckel B, Dumrese T, Stumm S, Kayser S, Moris A, Wallwiener D, Rammensee HG, Stevanovic S (2001) A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry. Cancer Res 61:4072–4077

    PubMed  CAS  Google Scholar 

  270. Schirle M, Weinschenk T, Stevanovic S (2001) Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J Immunol Methods 257:1–16

    Article  PubMed  CAS  Google Scholar 

  271. Bozzacco L, Yu H, Dengjel J, Trumpfheller C, Zebroski HA 3rd, Zhang N, Kuttner V, Ueberheide BM, Deng H, Chait BT, Steinman RM, Mojsov S, Fenyo D (2012) Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. PLoS One 7:e41897

    Article  PubMed  CAS  Google Scholar 

  272. Messitt TJ, Terry F, Moise L, Martin W, De Groot AS (2011) A comparison of two methods for T cell epitope mapping, “cell free” in vitro versus immunoinformatics. Immunome Res 7:6

    PubMed  Google Scholar 

  273. Nakayasu ES, Sobreira TJ, Torres R Jr, Ganiko L, Oliveira PS, Marques AF, Almeida IC (2012) Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi. J Proteome Res 11:237–246

    Article  PubMed  CAS  Google Scholar 

  274. Caron E, Vincent K, Fortier MH, Laverdure JP, Bramoulle A, Hardy MP, Voisin G, Roux PP, Lemieux S, Thibault P, Perreault C (2011) The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol 7:533

    Article  PubMed  CAS  Google Scholar 

  275. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scarselli M, Storni E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E, Mason T, Tettelin H, Hood DW, Jeffries AC, Saunders NJ, Granoff DM, Venter JC, Moxon ER, Grandi G, Rappuoli R (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816–1820

    Article  PubMed  CAS  Google Scholar 

  276. Sano T, Smith CL, Cantor CR (1992) Immuno-PCR, very sensitive antigen detection by means of specific antibody-DNA conjugates. Science 258:120–122

    Article  PubMed  CAS  Google Scholar 

  277. Niemeyer CM, Adler M, Wacker R (2007) Detecting antigens by quantitative immuno-PCR. Nat Protoc 2:1918–1930

    Article  PubMed  CAS  Google Scholar 

  278. Kasai N, Kobayashi K, Shioya S, Yoshikawa Y, Yotsumoto F, Miyamoto S, Mekada E, Enokizono J (2012) Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancer. Am J Transl Res 4:415–421

    PubMed  CAS  Google Scholar 

  279. Kuczius T, Becker K, Fischer A, Zhang W (2012) Simultaneous detection of three CNS indicator proteins in complex suspensions using a single immuno-PCR protocol. Anal Biochem 431:4–10

    Article  PubMed  CAS  Google Scholar 

  280. Hashimoto M, Aoki M, Winblad B, Tjernberg LO (2012) A novel approach for Abeta(1)(−)(4)(0) quantification using immuno-PCR. J Neurosci Methods 205:364–367

    Article  PubMed  CAS  Google Scholar 

  281. Malou N, Renvoise A, Nappez C, Raoult D (2012) Immuno-PCR for the early serological diagnosis of acute infectious diseases, the Q fever paradigm. Eur J Clin Microbiol Infect Dis 31:1951–1960

    Article  PubMed  CAS  Google Scholar 

  282. Potuckova L, Franko F, Bambouskova M, Draber P (2011) Rapid and sensitive detection of cytokines using functionalized gold nanoparticle-based immuno-PCR, comparison with immuno-PCR and ELISA. J Immunol Methods 371:38–47

    Article  PubMed  CAS  Google Scholar 

  283. Chao HY, Wang YC, Tang SS, Liu HW (2004) A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A. Toxicon 43:27–34

    Article  PubMed  CAS  Google Scholar 

  284. Allen RC, Rogelj S, Cordova SE, Kieft TL (2006) An immuno-PCR method for detecting Bacillus thuringiensis Cry1Ac toxin. J Immunol Methods 308:109–115

    Article  PubMed  CAS  Google Scholar 

  285. Fischer A, von Eiff C, Kuczius T, Omoe K, Peters G, Becker K (2007) A quantitative real-time immuno-PCR approach for detection of staphylococcal enterotoxins. J Mol Med (Berl) 85:461–469

    Article  CAS  Google Scholar 

  286. Zhang W, Bielaszewska M, Pulz M, Becker K, Friedrich AW, Karch H, Kuczius T (2008) New immuno-PCR assay for detection of low concentrations of shiga toxin 2 and its variants. J Clin Microbiol 46:1292–1297

    Article  PubMed  CAS  Google Scholar 

  287. He X, Qi W, Quinones B, McMahon S, Cooley M, Mandrell RE (2011) Sensitive detection of Shiga Toxin 2 and some of its variants in environmental samples by a novel immuno-PCR assay. Appl Environ Microbiol 77:3558–3564

    Article  PubMed  CAS  Google Scholar 

  288. Adler M (2005) Immuno-PCR as a clinical laboratory tool. Adv Clin Chem 39:239–292

    Article  PubMed  Google Scholar 

  289. Adler M, Wacker R, Niemeyer CM (2003) A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins. Biochem Biophys Res Commun 308:240–250

    Article  PubMed  CAS  Google Scholar 

  290. Lind K, Kubista M (2005) Development and evaluation of three real-time immuno-PCR assemblages for quantification of PSA. J Immunol Methods 304:107–116

    Article  PubMed  CAS  Google Scholar 

  291. Niemeyer CM, Adler M, Wacker R (2005) Immuno-PCR, high sensitivity detection of proteins by nucleic acid amplification. Trends Biotechnol 23:208–216

    Article  PubMed  CAS  Google Scholar 

  292. Malou N, Raoult D (2011) Immuno-PCR, a promising ultrasensitive diagnostic method to detect antigens and antibodies. Trends Microbiol 19:295–302

    Article  PubMed  CAS  Google Scholar 

  293. Ferreira L, Sanchez-Juanes F, Munoz-Bellido JL, Gonzalez-Buitrago JM (2011) Rapid method for direct identification of bacteria in urine and blood culture samples by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, intact cell vs. extraction method. Clin Microbiol Infect 17:1007–1012

    Article  PubMed  CAS  Google Scholar 

  294. Welker M (2011) Proteomics for routine identification of microorganisms. Proteomics 11:3143–3153

    Article  PubMed  CAS  Google Scholar 

  295. Welker M, Moore ER (2011) Applications of whole-cell matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry in systematic microbiology. Syst Appl Microbiol 34:2–11

    Article  PubMed  CAS  Google Scholar 

  296. Sogawa K, Watanabe M, Sato K, Segawa S, Miyabe A, Murata S, Saito T, Nomura F (2012) Rapid identification of microorganisms by mass spectrometry, improved performance by incorporation of in-house spectral data into a commercial database. Anal Bioanal Chem 403:1811–1822

    Article  PubMed  CAS  Google Scholar 

  297. El-Bouri K, Johnston S, Rees E, Thomas I, Bome-Mannathoko N, Jones C, Reid M, Ben-Ismaeil B, Davies AR, Harris LG, Mack D (2012) Comparison of bacterial identification by MALDI-TOF mass spectrometry and conventional diagnostic microbiology methods, agreement, speed and cost implications. Br J Biomed Sci 69:47–55

    PubMed  CAS  Google Scholar 

  298. Ouedraogo R, Flaudrops C, Ben Amara A, Capo C, Raoult D, Mege JL (2010) Global analysis of circulating immune cells by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. PLoS One 5:e13691

    Article  PubMed  CAS  Google Scholar 

  299. Ouedraogo R, Daumas A, Ghigo E, Capo C, Mege JL, Textoris J (2012) Whole-cell MALDI-TOF MS, a new tool to assess the multifaceted activation of macrophages. J Proteomics 75:5523–5532

    Article  PubMed  CAS  Google Scholar 

  300. Nuti DE, Crump RB, Dwi Handayani F, Chantratita N, Peacock SJ, Bowen R, Felgner PL, Davies DH, Wu T, Lyons CR, Brett PJ, Burtnick MN, Kozel TR, AuCoin DP (2011) Identification of circulating bacterial antigens by in vivo microbial antigen discovery. MBio 16:e00136

    Google Scholar 

  301. Testa JS, Shetty V, Hafner J, Nickens Z, Kamal S, Sinnathamby G, Philip R (2012) MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. PLoS One 7:e48484

    Article  PubMed  CAS  Google Scholar 

  302. Testa JS, Shetty V, Sinnathamby G, Nickens Z, Hafner J, Kamal S, Zhang X, Jett M, Philip R (2012) Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response. J Infect Dis 205:647–655

    Article  PubMed  CAS  Google Scholar 

  303. Macela A, Stulik J, Hernychova L, Kroca M, Krocova Z, Kovarova H (1996) The immune response against Francisella tularensis live vaccine strain in Lps(n) and Lps(d) mice. FEMS Immunol Med Microbiol 13:235–238

    Article  PubMed  CAS  Google Scholar 

  304. Havlasova J, Hernychova L, Halada P, Pellantova V, Krejsek J, Stulik J, Macela A, Jungblut PR, Larsson P, Forsman M (2002) Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain. Proteomics 2:857–867

    Article  PubMed  CAS  Google Scholar 

  305. Janovska S, Pavkova I, Hubalek M, Lenco J, Macela A, Stulik J (2007) Identification of immunoreactive antigens in membrane proteins enriched fraction from Francisella tularensis LVS. Immunol Lett 108:151–159

    Article  PubMed  CAS  Google Scholar 

  306. Twine SM, Petit MD, Fulton KM, House RV, Conlan JW (2010) Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS). PLoS One 5:e10000

    Article  PubMed  CAS  Google Scholar 

  307. Tan X, Chun S, Pablo J, Felgner P, Liang X, Davies DH (2012) Failure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naive individuals is related to differences in antibody profiles before vaccination, not after. Clin Vaccine Immunol 19:418–428

    Article  PubMed  CAS  Google Scholar 

  308. Hermanson G, Chun S, Felgner J, Tan X, Pablo J, Nakajima-Sasaki R, Molina DM, Felgner PL, Liang X, Davies DH (2012) Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax((R)) using proteome microarrays and development of recombinant protein ELISAs. Vaccine 30:614–625

    Article  PubMed  CAS  Google Scholar 

  309. Cook SD, Quinless JR, Jotkowitz A, Beaton P (2001) Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patients. Neurology 57:1080–1084

    Article  PubMed  CAS  Google Scholar 

  310. Bertolotto A, Malucchi S, Sala A, Orefice G, Carrieri PB, Capobianco M, Milano E, Melis F, Giordana MT (2002) Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis, a follow up study in an independent laboratory. J Neurol Neurosurg Psychiatry 73:148–153

    Article  PubMed  CAS  Google Scholar 

  311. Bertolotto A, Sala A, Malucchi S, Marnetto F, Caldano M, Di Sapio A, Capobianco M, Gilli F (2004) Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. J Neurol Neurosurg Psychiatry 75:1294–1299

    Article  PubMed  CAS  Google Scholar 

  312. Von Wussow P, Hehlmann R, Hochhaus T, Jakschies D, Nolte KU, Prummer O, Ansari H, Hasford J, Heimpel H, Deicher H (1994) Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia. J Interferon Res 14:217–219

    Article  Google Scholar 

  313. Ryff JC (1997) Clinical investigation of the immunogenicity of interferon-alpha 2a. J Interferon Cytokine Res 17(Suppl 1):S29–S33

    PubMed  CAS  Google Scholar 

  314. Baert F, Noman M, Vermeire S, Van Assche G, D' Haens G, Carbonez A, Rutgeerts P (2003) Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease. N Engl J Med 348:601–608

    Article  PubMed  CAS  Google Scholar 

  315. Radstake TR, Svenson M, Eijsbouts AM, van den Hoogen FH, Enevold C, van Riel PL, Bendtzen K (2009) Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. Ann Rheum Dis 68:1739–1745

    Article  PubMed  CAS  Google Scholar 

  316. Baker MP, Jones TD (2007) Identification and removal of immunogenicity in therapeutic proteins. Curr Opin Drug Discov Devel 10:219–227

    PubMed  CAS  Google Scholar 

  317. Baker MP, Reynolds HM, Lumicisi B, Bryson CJ (2010) Immunogenicity of protein therapeutics, The key causes, consequences and challenges. Self Nonself 1:314–322

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Human Health Therapeutics, National Research Council Canada, Ottawa, ON, Canada

    Kelly M. Fulton & Susan M. Twine

Authors
  1. Kelly M. Fulton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan M. Twine
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Research Council Canada Human Health Therapeutics, Ottawa, Ontario, Canada

    Kelly M. Fulton

  2. National Research Council Canada Human Health Therapeutics, Ottawa, Ontario, Canada

    Susan M. Twine

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Fulton, K.M., Twine, S.M. (2013). Immunoproteomics: Current Technology and Applications. In: Fulton, K., Twine, S. (eds) Immunoproteomics. Methods in Molecular Biology, vol 1061. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-589-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-589-7_2

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-588-0

  • Online ISBN: 978-1-62703-589-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation